Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: A systematic review and additional economic modelling of subgroup analyses
D. Wang, S. Bayliss, C. Meads*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
56Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: A systematic review and additional economic modelling of subgroup analyses'. Together they form a unique fingerprint.